{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T18:55:34Z","timestamp":1778439334256,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Patient"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s40271-021-00539-7","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T01:02:15Z","timestamp":1628470935000},"page":"207-218","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Identifying Unmet Care Needs and Important Treatment Attributes in the Management of Hidradenitis Suppurativa: A Qualitative Interview Study"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8263-4047","authenticated-orcid":false,"given":"Damon","family":"Willems","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4274-9258","authenticated-orcid":false,"given":"Mickael","family":"Hiligsmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hessel H","family":"van der Zee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1026-570X","authenticated-orcid":false,"given":"Silvia M A A","family":"Evers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,9]]},"reference":[{"issue":"1","key":"539_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41702-019-0052-0","volume":"4","author":"K Phan","year":"2020","unstructured":"Phan K, Charlton O, Smith SD. Global prevalence of hidradenitis suppurativa and geographical variation: systematic review and meta-analysis. Biomed Dermatol. 2020;4(1):1\u20136.","journal-title":"Biomed Dermatol"},{"issue":"2","key":"539_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMcp1014163","volume":"366","author":"GB Jemec","year":"2012","unstructured":"Jemec GB. Clinical practice: hidradenitis suppurativa. N Engl J Med. 2012;366(2):158\u201364.","journal-title":"N Engl J Med"},{"issue":"4","key":"539_CR3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jdv.12966","volume":"29","author":"CC Zouboulis","year":"2015","unstructured":"Zouboulis CC, Desai N, Emtestam L, Hunger RE, Ioannides D, Juhasz I, et al. European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa. J Eur Acad Dermatol Venereol. 2015;29(4):619\u201344.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"539_CR4","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/jdv.15940","volume":"34","author":"N Kirsten","year":"2020","unstructured":"Kirsten N, Petersen J, Hagenstrom K, Augustin M. Epidemiology of hidradenitis suppurativa in Germany: an observational cohort study based on a multisource approach. J Eur Acad Dermatol Venereol. 2020;34(1):174\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"539_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000431175","volume":"231","author":"CC Zouboulis","year":"2015","unstructured":"Zouboulis CC, Del Marmol V, Mrowietz U, Prens EP, Tzellos T, Jemec GB. Hidradenitis suppurativa\/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation. Dermatology. 2015;231(2):184\u201390.","journal-title":"Dermatology"},{"issue":"5","key":"539_CR6","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ijwd.2019.06.026","volume":"5","author":"A Cartron","year":"2019","unstructured":"Cartron A, Driscoll MS. Comorbidities of hidradenitis suppurativa: a review of the literature. Int J Womens Dermatol. 2019;5(5):330\u20134.","journal-title":"Int J Womens Dermatol."},{"issue":"2","key":"539_CR7","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/jdv.12567","volume":"29","author":"E Shavit","year":"2015","unstructured":"Shavit E, Dreiher J, Freud T, Halevy S, Vinker S, Cohen AD. Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2015;29(2):371\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"539_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1468-3083.2012.04468.x","volume":"27","author":"AJ Onderdijk","year":"2013","unstructured":"Onderdijk AJ, van der Zee HH, Esmann S, Lophaven S, Dufour DN, Jemec GB, et al. Depression in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2013;27(4):473\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"539_CR9","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","volume":"161","author":"K Sartorius","year":"2009","unstructured":"Sartorius K, Emtestam L, Jemec GB, Lapins J. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol. 2009;161(4):831\u20139.","journal-title":"Br J Dermatol"},{"issue":"3","key":"539_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2340\/00015555-1082","volume":"91","author":"S Esmann","year":"2011","unstructured":"Esmann S, Jemec GB. Psychosocial impact of hidradenitis suppurativa: a qualitative study. Acta Derm Venereol. 2011;91(3):328\u201332.","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"539_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/09546634.2016.1187707","volume":"28","author":"AB Fleischer Jr","year":"2017","unstructured":"Fleischer AB Jr. Characterization of obesity rates for dermatologic ambulatory office visits to United States physicians. J Dermatol Treat. 2017;28(2):181\u20135.","journal-title":"J Dermatol Treat"},{"issue":"2","key":"539_CR12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.5021\/ad.2016.28.2.147","volume":"28","author":"ZV Lim","year":"2016","unstructured":"Lim ZV, Oon HH. Management of hidradenitis suppurativa in patients with metabolic comorbidities. Ann Dermatol. 2016;28(2):147\u201351.","journal-title":"Ann Dermatol"},{"issue":"5 Suppl. 1","key":"539_CR13","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1016\/j.jaad.2015.07.054","volume":"73","author":"M Gooderham","year":"2015","unstructured":"Gooderham M, Papp K. The psychosocial impact of hidradenitis suppurativa. J Am Acad Dermatol. 2015;73(5 Suppl. 1):S19-22.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"539_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2340\/00015555-2129","volume":"96","author":"PT Riis","year":"2016","unstructured":"Riis PT, Vinding GR, Ring HC, Jemec GB. Disutility in patients with hidradenitis suppurativa: a cross-sectional study using EuroQoL-5D. Acta Derm Venereol. 2016;96(2):222\u20136.","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"539_CR15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1159\/000508787","volume":"236","author":"G Kokolakis","year":"2020","unstructured":"Kokolakis G, Wolk K, Schneider-Burrus S, Kalus S, Barbus S, Gomis-Kleindienst S, et al. Delayed diagnosis of hidradenitis suppurativa and its effect on patients and healthcare system. Dermatology. 2020;236(5):421\u201330.","journal-title":"Dermatology"},{"issue":"2","key":"539_CR16","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jaad.2019.06.1301","volume":"82","author":"A Garg","year":"2020","unstructured":"Garg A, Neuren E, Cha D, Kirby JS, Ingram JR, Jemec GBE, et al. Evaluating patients\u2019 unmet needs in hidradenitis suppurativa: results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project. J Am Acad Dermatol. 2020;82(2):366\u201376.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"539_CR17","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1111\/bjd.14038","volume":"173","author":"DM Saunte","year":"2015","unstructured":"Saunte DM, Boer J, Stratigos A, Szepietowski JC, Hamzavi I, Kim KH, et al. Diagnostic delay in hidradenitis suppurativa is a global problem. Br J Dermatol. 2015;173(6):1546\u20139.","journal-title":"Br J Dermatol"},{"issue":"2","key":"539_CR18","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.clindermatol.2016.10.018","volume":"35","author":"RK Andersen","year":"2017","unstructured":"Andersen RK, Jemec GB. Treatments for hidradenitis suppurativa. Clin Dermatol. 2017;35(2):218\u201324.","journal-title":"Clin Dermatol"},{"issue":"5","key":"539_CR19","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jaad.2019.08.089","volume":"82","author":"SR Goldburg","year":"2020","unstructured":"Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa: current and emerging treatments. J Am Acad Dermatol. 2020;82(5):1061\u201382.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"539_CR20","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1111\/bjd.16768","volume":"183","author":"KR van Straalen","year":"2020","unstructured":"van Straalen KR, Schneider-Burrus S, Prens EP. Current and future treatment of hidradenitis suppurativa. Br J Dermatol. 2020;183(6):e178\u201387.","journal-title":"Br J Dermatol"},{"issue":"4","key":"539_CR21","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jaad.2010.07.010","volume":"65","author":"C Schlapbach","year":"2011","unstructured":"Schlapbach C, Hanni T, Yawalkar N, Hunger RE. Expression of the IL-23\/Th17 pathway in lesions of hidradenitis suppurativa. J Am Acad Dermatol. 2011;65(4):790\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"539_CR22","doi-asserted-by":"crossref","unstructured":"Willems D, Rolleri B, Pansar I, Kroi F, Hashim M. A systematic literature review and early network meta-analysis of current and future treatments for moderate to severe hidradenitis suppurativa. Value Health. 2020;23(S410).","DOI":"10.1016\/j.jval.2020.08.080"},{"issue":"10","key":"539_CR23","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1007\/s00464-014-4044-2","volume":"29","author":"MP Ho","year":"2015","unstructured":"Ho MP, Gonzalez JM, Lerner HP, Neuland CY, Whang JM, McMurry-Heath M, et al. Incorporating patient-preference evidence into regulatory decision making. Surg Endosc. 2015;29(10):2984\u201393.","journal-title":"Surg Endosc"},{"key":"539_CR24","unstructured":"GU. NICE to research patient preferences in HTA. PharmaTimes. 2016."},{"issue":"8","key":"539_CR25","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1080\/03007995.2020.1776233","volume":"36","author":"N Sain","year":"2020","unstructured":"Sain N, Willems D, Charokopou M, Hiligsmann M. The importance of understanding patient and physician preferences for psoriasis treatment characteristics: a systematic review of discrete-choice experiments. Curr Med Res Opin. 2020;36(8):1257\u201375.","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"539_CR26","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1017\/S0266462311000523","volume":"27","author":"M Danner","year":"2011","unstructured":"Danner M, Hummel JM, Volz F, van Manen JG, Wiegard B, Dintsios CM, et al. Integrating patients\u2019 views into health technology assessment: analytic hierarchy process (AHP) as a method to elicit patient preferences. Int J Technol Assess Health Care. 2011;27(4):369\u201375.","journal-title":"Int J Technol Assess Health Care"},{"issue":"6","key":"539_CR27","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/j.1468-3083.2012.04569.x","volume":"27","author":"N Umar","year":"2013","unstructured":"Umar N, Schaarschmidt M, Schmieder A, Peitsch WK, Schollgen I, Terris DD. Matching physicians\u2019 treatment recommendations to patients\u2019 treatment preferences is associated with improvement in treatment satisfaction. J Eur Acad Dermatol Venereol. 2013;27(6):763\u201370.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"539_CR28","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/bjd.15086","volume":"176","author":"RJ Thorneloe","year":"2017","unstructured":"Thorneloe RJ, Bundy C, Griffiths CE, Ashcroft DM, Cordingley L. Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis. Br J Dermatol. 2017;176(3):667\u201376.","journal-title":"Br J Dermatol"},{"issue":"1","key":"539_CR29","first-page":"106","volume":"10","author":"T Jevtic","year":"2013","unstructured":"Jevtic T, Bukumiric Z, Jankovic SM. Effects of treatment adherence on clinical and economic outcomes in patients with psoriasis. Med Glas (Zenica). 2013;10(1):106\u201312.","journal-title":"Med Glas (Zenica)"},{"key":"539_CR30","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1080\/13696998.2020.1840181","volume":"23","author":"D Willems","year":"2020","unstructured":"Willems D, Charokopou M, Evers S, Hiligsmann M. Early health economic modelling for a treatment candidate in hidradenitis suppurativa. J Med Econ. 2020;23:1516\u201324.","journal-title":"J Med Econ"},{"issue":"2","key":"539_CR31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40273-018-0734-2","volume":"37","author":"V Soekhai","year":"2019","unstructured":"Soekhai V, de Bekker-Grob EW, Ellis AR, Vass CM. Discrete choice experiments in health economics: past, present and future. Pharmacoeconomics. 2019;37(2):201\u201326.","journal-title":"Pharmacoeconomics"},{"issue":"11","key":"539_CR32","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.jval.2019.07.007","volume":"22","author":"RA Vreman","year":"2019","unstructured":"Vreman RA, Heikkinen I, Schuurman A, Sapede C, Garcia JL, Hedberg N, et al. Unmet medical need: an introduction to definitions and stakeholder perceptions. Value Health. 2019;22(11):1275\u201382.","journal-title":"Value Health"},{"issue":"1","key":"539_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2307\/2981886","volume":"149","author":"G Kalton","year":"1986","unstructured":"Kalton G, Anderson D. Sampling rare populations. J R Stat Soc A. 1986;149(1):65\u201382.","journal-title":"J R Stat Soc A"},{"issue":"5","key":"539_CR34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10488-013-0528-y","volume":"42","author":"LA Palinkas","year":"2015","unstructured":"Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health. 2015;42(5):533\u201344.","journal-title":"Adm Policy Ment Health"},{"issue":"1","key":"539_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40271-015-0122-3","volume":"9","author":"M Danner","year":"2016","unstructured":"Danner M, Vennedey V, Hiligsmann M, Fauser S, Stock S. Focus groups in elderly ophthalmologic patients: setting the stage for quantitative preference elicitation. Patient. 2016;9(1):47\u201357.","journal-title":"Patient"},{"issue":"1","key":"539_CR36","doi-asserted-by":"crossref","first-page":"238146831983792","DOI":"10.1177\/2381468319837925","volume":"4","author":"C Somers","year":"2019","unstructured":"Somers C, Chimonas S, McIntosh E, Kaltenboeck A, Briggs A, Bach P. Using nominal group technique to identify key attributes of oncology treatments for a discrete choice experiment. MDM Policy Pract. 2019;4(1):2381468319837925.","journal-title":"MDM Policy Pract."},{"issue":"10","key":"539_CR37","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1080\/08870440903194015","volume":"25","author":"JJ Francis","year":"2010","unstructured":"Francis JJ, Johnston M, Robertson C, Glidewell L, Entwistle V, Eccles MP, et al. What is an adequate sample size? Operationalising data saturation for theory-based interview studies. Psychol Health. 2010;25(10):1229\u201345.","journal-title":"Psychol Health"},{"issue":"7","key":"539_CR38","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jval.2017.11.014","volume":"21","author":"DM Turner-Bowker","year":"2018","unstructured":"Turner-Bowker DM, Lamoureux RE, Stokes J, Litcher-Kelly L, Galipeau N, Yaworsky A, et al. Informing a priori sample size estimation in qualitative concept elicitation interview studies for clinical outcome assessment instrument development. Value Health. 2018;21(7):839\u201342.","journal-title":"Value Health."},{"issue":"1","key":"539_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/13814788.2017.1375091","volume":"24","author":"A Moser","year":"2018","unstructured":"Moser A, Korstjens I. Series: practical guidance to qualitative research. Part 3: sampling, data collection and analysis. Eur J Gen Pract. 2018;24(1):9\u201318.","journal-title":"Eur J Gen Pract"},{"issue":"4","key":"539_CR40","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jval.2010.11.013","volume":"14","author":"JF Bridges","year":"2011","unstructured":"Bridges JF, Hauber AB, Marshall D, Lloyd A, Prosser LA, Regier DA, et al. Conjoint analysis applications in health\u2014a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;14(4):403\u201313.","journal-title":"Value Health"},{"issue":"5","key":"539_CR41","first-page":"E27","volume":"104","author":"EH Tracey","year":"2019","unstructured":"Tracey EH. Don\u2019t forget these 5 things when treating hidradenitis suppurativa. Cutis. 2019;104(5):E27\u20138.","journal-title":"Cutis"},{"issue":"6","key":"539_CR42","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00403-019-02027-3","volume":"312","author":"S Fisher","year":"2020","unstructured":"Fisher S, Jehassi A, Ziv M. Hidradenitis suppurativa on Facebook: thematic and content analyses of patient support group. Arch Dermatol Res. 2020;312(6):421\u20136.","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"539_CR43","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/j.jaad.2018.08.031","volume":"80","author":"NM Golbari","year":"2019","unstructured":"Golbari NM, Porter ML, Kimball AB. Online communications among hidradenitis suppurativa patients reflect community needs. J Am Acad Dermatol. 2019;80(6):1760\u20132.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"539_CR44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/1203475417736290","volume":"22","author":"W Gulliver","year":"2018","unstructured":"Gulliver W, Landells IDR, Morgan D, Pirzada S. Hidradenitis suppurativa: a novel model of care and an integrative strategy to adopt an orphan disease. J Cutan Med Surg. 2018;22(1):71\u20137.","journal-title":"J Cutan Med Surg"},{"issue":"6","key":"539_CR45","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jaad.2017.07.027","volume":"77","author":"IH Hamzavi","year":"2017","unstructured":"Hamzavi IH, Sundaram M, Nicholson C, Zivkovic M, Parks-Miller A, Lee J, et al. Uncovering burden disparity: a comparative analysis of the impact of moderate-to-severe psoriasis and hidradenitis suppurativa. J Am Acad Dermatol. 2017;77(6):1038\u201346.","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"539_CR46","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1111\/jdv.13687","volume":"30","author":"V Bettoli","year":"2016","unstructured":"Bettoli V, Pasquinucci S, Caracciolo S, Piccolo D, Cazzaniga S, Fantini F, et al. The hidradenitis suppurativa patient journey in Italy: current status, unmet needs and opportunities. J Eur Acad Dermatol Venereol. 2016;30(11):1965\u201370.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"539_CR47","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2340\/00015555-2513","volume":"97","author":"B Horvath","year":"2017","unstructured":"Horvath B, Janse IC, Blok JL, Driessen RJ, Boer J, Mekkes JR, et al. Hurley staging refined: a proposal by the Dutch Hidradenitis Suppurativa Expert Group. Acta Derm Venereol. 2017;97(3):412\u20133.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"539_CR48","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s40271-019-00401-x","volume":"13","author":"IL Hollin","year":"2020","unstructured":"Hollin IL, Craig BM, Coast J, Beusterien K, Vass C, DiSantostefano R, et al. Reporting formative qualitative research to support the development of quantitative preference study protocols and corresponding survey instruments: guidelines for authors and reviewers. Patient. 2020;13(1):121\u201336.","journal-title":"Patient"},{"issue":"1","key":"539_CR49","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1001\/jamadermatol.2020.4494","volume":"157","author":"MT Taylor","year":"2021","unstructured":"Taylor MT, Orenstein LAV, Barbieri JS. Pain severity and management of hidradenitis suppurativa at US emergency department visits. JAMA Dermatol. 2021;157(1):115\u20137.","journal-title":"JAMA Dermatol"},{"issue":"3","key":"539_CR50","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/bjd.16093","volume":"178","author":"L Thorlacius","year":"2018","unstructured":"Thorlacius L, Garg A, Ingram JR, Villumsen B, Theut Riis P, Gottlieb AB, et al. Towards global consensus on core outcomes for hidradenitis suppurativa research: an update from the HISTORIC consensus meetings I and II. Br J Dermatol. 2018;178(3):715\u201321.","journal-title":"Br J Dermatol"},{"issue":"3","key":"539_CR51","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/bjd.16672","volume":"179","author":"L Thorlacius","year":"2018","unstructured":"Thorlacius L, Ingram JR, Villumsen B, Esmann S, Kirby JS, Gottlieb AB, et al. A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process. Br J Dermatol. 2018;179(3):642\u201350.","journal-title":"Br J Dermatol"},{"issue":"1","key":"539_CR52","doi-asserted-by":"publisher","first-page":"R36","DOI":"10.1186\/ar4465","volume":"16","author":"M Hiligsmann","year":"2014","unstructured":"Hiligsmann M, Dellaert BG, Dirksen CD, van der Weijden T, Goemaere S, Reginster JY, et al. Patients\u2019 preferences for osteoporosis drug treatment: a discrete-choice experiment. Arthritis Res Ther. 2014;16(1):R36.","journal-title":"Arthritis Res Ther"}],"container-title":["The Patient - Patient-Centered Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-021-00539-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40271-021-00539-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-021-00539-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T15:05:26Z","timestamp":1675609526000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40271-021-00539-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,9]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["539"],"URL":"https:\/\/doi.org\/10.1007\/s40271-021-00539-7","relation":{},"ISSN":["1178-1653","1178-1661"],"issn-type":[{"value":"1178-1653","type":"print"},{"value":"1178-1661","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,9]]},"assertion":[{"value":"15 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received for the conduct of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"DW is a registered PhD student at Maastricht University and an employee of UCB Pharma, UCB Pharma had no role in the design, conduct, and analysis of the study, or in the writing\/reviewing of this manuscript. All other authors declare no conflict of interest for the conduct and presentation of this research, but HvZ declares to have received consultancy fees from AbbVie, InflaRx, and Novartis and CS declares to have received honoraria paid to an institution as an investigator for AbbVie, Chemocentryx, Incyte, InflaRx, Novartis, and UCB Pharma; consultancy fees from AbbVie and InflaRx; speaking fees for AbbVie and Novartis; and consulting fees paid to an institution from UCB Pharma.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of Maastricht University and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The submission does not include personal details or images that may lead to the identification of participants and all participants gave consent to publish their anonymized data.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by\u00a0all authors. The manuscript was written by DW and all authors provided feedback throughout the development of the manuscript. All authors read and approved the final manuscript. All authors sufficiently contributed to this research according to ICMJE criteria to qualify as a listed author.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}